Patents by Inventor Danilo A. Tagle

Danilo A. Tagle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genes for Niemann-Pick type C disease
    Patent number: 7045675
    Abstract: A gene for type C Niemann-Pick disease (NP-C) is disclosed, along with the amino acid sequence of the encoded peptide. Applications which are made possible by the present invention include detection of NP-C carriers and diagnosis of NP-C sufferers. The murine ortholog of the human gene is also disclosed.
    Type: Grant
    Filed: July 29, 2002
    Date of Patent: May 16, 2006
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Eugene D Carstea, Danilo A. Tagle, Jill A. Morris, Peter G. Pentchev, William J. Pavan, Melissa A. Ashlock, Stacie K. Loftus, Jessie Gu
  • Genes for Niemann-Pick type C disease
    Publication number: 20030092038
    Abstract: A gene for type C Niemann-Pick disease (NP-C) is disclosed, along with the amino acid sequence of the encoded peptide. Applications which are made possible by the present invention include detection of NP-C carriers and diagnosis of NP-C sufferers. The murine ortholog of the human gene is also disclosed.
    Type: Application
    Filed: July 29, 2002
    Publication date: May 15, 2003
    Applicant: The Govt. of the USA, as represented by the Secretary of the Dept. of Health & Human Services
    Inventors: Eugene D. Carstea, Danilo A. Tagle, Jill A. Morris, Peter G. Pentchev, William J. Pavan, Melissa A. Ashlock, Stacie K. Loftus, Jessie Gu
  • Genes for Niemann-Pick type C disease
    Patent number: 6426198
    Abstract: A gene for type C Niemann-Pick disease (NP-C) is disclosed, along with the amino acid sequence of the encoded peptide. Applications which are made possible by the present invention include detection of NP-C carriers and diagnosis of NP-C sufferers. The murine ortholog of the human gene is also disclosed.
    Type: Grant
    Filed: June 1, 1999
    Date of Patent: July 30, 2002
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Eugene D. Carstea, Danilo A. Tagle, Jill A. Morris, Peter G. Pentchev, William J. Pavan, Melissa A. Ashlock, Stacie K. Loftus, Jessie Gu
  • Ataxia-telangiectasia gene
    Patent number: 6211336
    Abstract: There is provided a purified amino acid sequence selected from the group of Sequence ID No.: 3 and analogs thereof and mutations of Sequence ID No.: 3 which cause ataxia-telangiectasia. Also provided is a purified amino acid sequence as set forth in Sequence ID No.: 3 and analogs thereof.
    Type: Grant
    Filed: February 26, 1998
    Date of Patent: April 3, 2001
    Assignees: The United States of America as represented by the Department of Health and Human Services, Ramot University Authority for Applied Research and Industrial Dev.
    Inventors: Yosef Shiloh, Danilo A. Tagle, Francis Collins
  • cDNAs associated with ataxia-telangiectasia
    Patent number: 5777093
    Abstract: A purified and isolated gene, designated ATM, mutations of which cause ataxia-telangiectasia.
    Type: Grant
    Filed: July 28, 1995
    Date of Patent: July 7, 1998
    Assignee: RAMOT-University Authority for Applied Research & Industrial Development Ltd.
    Inventors: Yosef Shiloh, Danilo A. Tagle, Francis S. Collins
  • Mutated proteins associated with ataxia-telangiectasia
    Patent number: 5728807
    Abstract: A purified and isolated gene, designated ATM, mutations of which cause ataxia-telangiectasia.
    Type: Grant
    Filed: June 21, 1995
    Date of Patent: March 17, 1998
    Assignee: Ramot-University Authority For Applied Research and Industrial Development, Ltd.
    Inventors: Yosef Shiloh, Danilo A. Tagle, Francis S. Collins